Polymyalgia Rheumatica Pmr clinical trials

Explore recruiting polymyalgia rheumatica pmr clinical trials.

Recruiting polymyalgia rheumatica pmr studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Polymyalgia Rheumatica Pmr trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A trial of prednisolone in combination with SPI-62 in participants with polymyalgia rheumatica (PMR)

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Justification AnD evaluation, in pOlymyalgia RhEumatica, of BARIcitinib versus placebo (JADORE-BARI study)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A trial of prednisolone in combination with SPI-62 or placebo in participants with polymyalgia rheumatica (PMR)

Germany, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A multi-center, open-label extension study of subcutaneous secukinumab to evaluate the long-term safety and tolerability in polymyalgia rheumatica (PMR)

Italy, Germany, Spain, Denmark, Netherlands, France +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of each of two dose levels of sarilumab in adults with early polymyalgia rheumatica

France, Netherlands, Germany, Czechia, Belgium, Austria +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized, parallel-group, double-blind, placebo-controlled, multicenter Phase III trial to evaluate efficacy and safety of secukinumab administered subcutaneously versus placebo, in combination with a glucocorticoid taper regimen, in patients with polymyalgia rheumatica (PMR)

Denmark, Italy, France, Germany, Netherlands, Hungary +9 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Polymyalgia Rheumatica Pmr trials by city

Polymyalgia Rheumatica Pmr clinical trials

Recruiting polymyalgia rheumatica pmr studies right now

Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency

Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica

Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty

Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment

Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica

Justification And Evaluation of Baricitinib Plus Corticosteroids Versus corticosteroiDs Alone in pOlymyalgia RhEumatica

Also recruiting in Europe

A trial of prednisolone in combination with SPI-62 in participants with polymyalgia rheumatica (PMR)

Justification AnD evaluation, in pOlymyalgia RhEumatica, of BARIcitinib versus placebo (JADORE-BARI study)

A trial of prednisolone in combination with SPI-62 or placebo in participants with polymyalgia rheumatica (PMR)

A multi-center, open-label extension study of subcutaneous secukinumab to evaluate the long-term safety and tolerability in polymyalgia rheumatica (PMR)

A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of each of two dose levels of sarilumab in adults with early polymyalgia rheumatica

A randomized, parallel-group, double-blind, placebo-controlled, multicenter Phase III trial to evaluate efficacy and safety of secukinumab administered subcutaneously versus placebo, in combination with a glucocorticoid taper regimen, in patients with polymyalgia rheumatica (PMR)

Polymyalgia Rheumatica Pmr trials by city

Other conditions